Abstract
Measuring blood pressure during pregnancy is an essential component of antenatal care, and is critical for detecting adverse conditions such as pre-eclampsia. The standard approach for measuring blood pressure is via manual auscultation by a trained expert or via an oscillometric self-inflating cuff. While both methods can provide reasonably accurate blood pressure measurements when used correctly, non-expert use can lead to significant error. Moreover, such techniques are uncomfortable and can cause bruising, pain and consequential resistance to use / low compliance. In this work, we propose a low-cost onedimensional Doppler-based method for the detection of hypertension in pregnancy.
Using a sample of 653 pregnant women of Mayan descent in highland Guatemala, we recorded up to 10 minutes of 1D Doppler data of the fetus, and blood pressure from both arms using an Omron M7 oscillometric cuff. A hierarchical LSTM network with attention mechanism was trained to classify hypertension in pregnancy, producing an area under the receiveroperator curve of 0.94. A projection of the data into lower dimensions indicates hypertensive cases are located at the periphery of the distribution of the output of the distribution.
This work presents the first demonstration that blood pressure can be measured using Doppler (without occlusion) and may lead to a novel class of blood pressure monitors which allow rapid blood pressure estimation from multiple body locations. Moreover, the association of the predictor with the fetal blood flow indicates that hypertension in the mother has a significant effect on the fetal blood flow.
Competing Interest Statement
In the last three years GC has received research funding from the NSF, NIH and LifeBell AI, and unrestricted donations from AliveCor, Amazon Research, the Center for Discovery, the Gordon and Betty Moore Foundation, MathWorks, Microsoft Research, the Gates Foundation, Google, One Mind Foundation, and Samsung Research. GC has financial interest in AliveCor, and receives unrestricted funding from the company. GC also is the CTO of MindChild Medical and CSO of LifeBell AI and has ownership in both companies. These relationships are unconnected to the current work, although these entities may later license work.
Funding Statement
The research presented here was funded by a Global Health Grant from Emory University. GC acknowledges the support of the National Institutes of Health, the Fogarty International Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, grant number 1R21HD084114-01 (Mobile Health Intervention to Improve Perinatal Continuum of Care in Guatemala), which enabled the collection of the data in this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Boards of Emory University, the Wuqu' Kawoq | Maya Health Alliance, and Agnes Scott College (Ref: IRB00076231 - `Mobile Health Intervention to Improve Perinatal Continuum of Care in Guatemala') gave ethical approval for this work. It has also been registered as a clinical trial (ClinicalTrials.gov identifier NCT02348840).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study will be the subject of a future competition and released at that date.
